From: news-medical.net Breast cancer is the deadliest and most common type of cancer in women. The treatment options often require administration of anti-cancer drugs in high doses, as the cells develop resistance towards chemotherapy, leading to painful side effects in patients. Recently researchers have identified that reducing the level of a protein called DSS1 can increase patients’ responsiveness to chemotherapy, …
Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer
Source: Karolinska Institutet From: eurekalert.org While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have …
A group of cancer doctors discovered a way to slash the cost of expensive pills by up to 75%, but they’ve hit a wall
By: Lydia Ramsey From: businessinsider.com The cost of certain cancer drugs has gotten high, often to more than $100,000 a year. To combat that, researchers are looking for treatments that could be taken at a lower dose, so long as they’re taken with food. But finding the funding to study lower doses hasn’t been easy. Dr. Mark Ratain, the chief …